A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix

Bibliography

• Bryce J, Boschi-Pinto C, Shibuya K, et al. WHO estimates of the causes of death in children. Lancet 2005;365:1147-52
   PubMed Web of Science ®Google Scholar
• Hart CA, Cunliffe NA, Nakagomi O. Diarrhoea caused by viruses. In: Cook GC, Zumla AI, editors, Manson's Tropical Diseases, 22nd edition, Philadelphia: Saunders; 2009. p. 815-24
   Google Scholar
• Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006;12:304-6
   PubMed Web of Science ®Google Scholar
• Naghipour M, Nakagomi T, Nakagomi O. Issues with reducing the rotavirus-associated mortality by vaccination in developing countries. Vaccine 2008;26:3236-41
   PubMed Web of Science ®Google Scholar
• Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006;25(Suppl):S7-11
   PubMed Web of Science ®Google Scholar
• Bishop RF, Davidson GP, Holmes IH, Ruck BJ. Virus particles in epithelial cells of duodenal mucosa from children with acute non-bacterial gastroenteritis. Lancet 1973;2:1281-3
   PubMed Web of Science ®Google Scholar
• Kapikian AZ, Wyatt RG, Levine MM, et al. Studies in volunteers with human rotaviruses. Dev Biol Stand 1983;53:209-18
   PubMedGoogle Scholar
• Vesikari T, Isolauri E, D'Hondt E, et al. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984;1:977-81
   PubMed Web of Science ®Google Scholar
• Vesikari T, Isolauri E, Delem A, et al. Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemic. J Pediatr 1985;107:189-94
   PubMed Web of Science ®Google Scholar
• Vesikari T. Rotavirus vaccines. Scand J Infect Dis 2008;40:691-5
   PubMed Web of Science ®Google Scholar
• De Mol P, Zissis G, Butzler JP, et al. Failure of live, attenuated oral rotavirus vaccine. Lancet 1986;2:108
   PubMed Web of Science ®Google Scholar
• Hanlon P, Hanlon L, Marsh V, et al. Trial of an attenuated bovine rotavirus vaccine (RIT 4237) in Gambian infants. Lancet 1987:1342-5
   PubMedGoogle Scholar
• Santosham M, Letson GW, Wolff M, et al. A field study of the safety and efficacy of two candidate rotavirus vaccines in a Native American population. J Infect Dis 1991;163:483-7
   PubMed Web of Science ®Google Scholar
• Vesikari T, Ruuska T, Delem A, et al. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea. Acta Paediatr Scand 1991;80:173-80
   PubMed Web of Science ®Google Scholar
• Pérez-Schael I, Guntiñas MJ, Pérez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. N Engl J Med 1997;337:1181-7
   PubMed Web of Science ®Google Scholar
• Nakagomi T. Rotavirus infection and intussusception: a view from retrospect. Microbiol Immunol 2000;44:619-28
   PubMed Web of Science ®Google Scholar
• Simonsen L, Viboud C, Elixhauser A, et al. More on RotaShield and intussusception: the role of age at the time of vaccination. J Infect Dis 2005;192(Suppl 1):S36-43
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33
   PubMed Web of Science ®Google Scholar
• Robbins FC. The history of polio vaccine development. In: Plotkin SA, Orenstein WA, editors, Vaccines, 3rd edition, Philadelphia: WB Saunders Co., 1999. p. 13-27
   Google Scholar
• World Health Organization. The WHO position paper on rotavirus vaccines. Wkly Epidemiol Rec 2007;82:285-96
   PubMedGoogle Scholar
• Unicomb LE, Faruque SM, Malek MA, et al. Demonstration of a lack of synergistic effect of rotavirus with other diarrheal pathogens on severity of diarrhea in children. J Clin Microbiol 1996;34:1340-2
   PubMed Web of Science ®Google Scholar
• Dickey M, Jamison L, Michaud L, et al. Rotavirus meningoencephalitis in a previously healthy child and a review of the literature. Pediatr Infect Dis J 2009;28:318-21
   PubMed Web of Science ®Google Scholar
• Blutt SE, Kirkwood CD, Parreno V, et al. Rotavirus antigenaemia and viraemia: a common event? Lancet 2003;362:1445-9
   PubMed Web of Science ®Google Scholar
• Nakagomi T, Nakagomi O. Rotavirus antigenemia in children with encephalopathy accompanied by rotavirus gastroenteritis. Arch Virol 2005;150:1927-31
   PubMed Web of Science ®Google Scholar
• Wilde J, Yolken R, Willoughby R, et al. Improved detection of rotavirus shedding by polymerase chain reaction. Lancet 1991;337:323-6
   PubMed Web of Science ®Google Scholar
• Richardson S, Grimwood K, Gorrell R, et al. Extended excretion of rotavirus after severe diarrhoea in young children. Lancet 1998;351:1844-8
   PubMed Web of Science ®Google Scholar
• Ball JM, Tian P, Zeng CQ, et al. Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 1996;272:101-4
   PubMed Web of Science ®Google Scholar
• Horie Y, Nakagomi O, Koshimura Y, et al. Diarrhea induction by rotavirus NSP4 in the homologous mouse model system. Virology 1999;262:398-407
   PubMed Web of Science ®Google Scholar
• Gentsch JR, Laird AR, Bielfelt B, et al. Serotype diversity and reassortment between human and animal rotavirus strains: implications for rotavirus vaccine programs. J Infect Dis 2005;192(Suppl 1):146-59
   PubMed Web of Science ®Google Scholar
• Santos N, Hoshino Y. Global distribution of rotavirus serotypes/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol 2005;15:29-56
   PubMed Web of Science ®Google Scholar
• Castello AA, Arguelles MH, Rota RP, et al. Molecular epidemiology of group A rotavirus diarrhea among children in Buenos Aires, Argentina, from 1999 to 2003 and emergence of the infrequent genotype G12. J Clin Microbiol 2006;44:2046-50
   PubMed Web of Science ®Google Scholar
• Uchida R, Pandey BD, Sherchand JB, et al. Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain. J Clin Microbiol 2006;44:3499-505
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Gentsch JR, Kirkwood CD, et al. Molecular and serologic characterization of novel serotype G8 human rotavirus strains detected in Blantyre, Malawi. Virology 2000;274:309-20
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Bresee JS, Gentsch JR, et al. The expanding diversity of rotaviruses. Lancet 2002;359:640-2
   PubMed Web of Science ®Google Scholar
• Nakagomi O, Nakagomi T. Genomic relationships among rotaviruses recovered from various animal species as revealed by RNA-RNA hybridization assays. Res Vet Sci 2002;73:207-14
   PubMed Web of Science ®Google Scholar
• Velazquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8
   PubMed Web of Science ®Google Scholar
• Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med 1983;309:72-6
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Sander DS, Smith VE, et al. Protection from rotavirus reinfection: 2-year prospective study. J Infect Dis 1991;164:277-83
   PubMed Web of Science ®Google Scholar
• Prescribing Information for Rotarix. Silver Spring, MD: FDA, 2009. Available from: fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM133539.pdf [Last accessed 16 June 2009]
   Google Scholar
• Rotavirus vaccines for Australian children: information for GPs and immunisation providers. Sydney, Australia: National Centre for Immunisation. October 2007. Available from: http://www.public.health.wa.gov.au/cproot/421/2/rotavirus_ vaccine_for_children_sep_2006.pdf [Last accessed 16 June 2009]
   Google Scholar
• Scientific discussion. London, UK: European Medicines Agency. Avaialable from: http://www.emea.europa.eu/humandocs/PDFs/epar/rotarix/ Rotarix-H-639-II-01-AR.pdf [Last accessed 16 June 2009]
   Google Scholar
• de Oliveira LH, Danovaro-Holliday MC, Matus CR, Andrus JK. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines 2008;7:345-53
   PubMed Web of Science ®Google Scholar
• Prescribing information for RotaTeq. Whithouse Station, NJ: Merck 1009. Available from: http://www.merck.com/product/usa/pi_circulars/r/rotateq/rotateq_pi.pdf [Last accessed 16 June 2009]
   Google Scholar
• Asessment report for Rotarix. Procedure N. EMEA/A/H/C/639/X/0010. London: European Medicines Agency, 26 June, 2008. Available from: http://www.emea.europa.eu/humandocs/PDFs/EPAR/rotarix/Rotarix-H-639-X-10-AR.pdf [Last accessed 16 June 2009]
   Google Scholar
• Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). Mortal Morb Wkly Rep Recomm Rep 2009;58(RR-2):1-25
   Google Scholar
• Committee on Infectious Diseases. Prevention of Rotavirus Disease: updated Guidelines for Use of Rotavirus Vaccine. Pediatrics 2009;123(5):1412-20
   PubMed Web of Science ®Google Scholar
• Bines JE, Liem NT, Justice FA, et al. Intussusception Study Group. Risk factors for intussusception in infants in Vietnam and Australia: adenovirus implicated,but not rotavirus. J Pediatr 2006;149:452-60
   PubMed Web of Science ®Google Scholar
• Chang EJ, Zangwill KM, Lee H, Ward JI. Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J 2002;21:97-102
   PubMed Web of Science ®Google Scholar
• Dennehy PH, Brady RC, Halperin SA, et al. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infec Dis J 2005;24:481-8
   PubMed Web of Science ®Google Scholar
• Salinas B, Perez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J 2005;24:807-16
   PubMed Web of Science ®Google Scholar
• Phua KB, Quak SH, Lee BW, et al: Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis 2005;192(Suppl 1):S6-16
   PubMed Web of Science ®Google Scholar
• Steele AD, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine. Published online 9 September 2008, doi:10.1016/J.Vaccine.2008.08.034
   Google Scholar
• Zaman K, Sack DA, Yunus M, et al. Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age. Vaccine 2009;27:1333-9
   PubMed Web of Science ®Google Scholar
• Clark HF, Borian FE, Bell LM, et al. Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season. J Infect Dis 1988;158:570-87
   PubMed Web of Science ®Google Scholar
• Ward RL, Bernstein DI. Rotarix: a rotavirus vaccine for the world. Clin Infect Dis 2009;48:222-8
   PubMed Web of Science ®Google Scholar
• Bernstein DI, Sack DA, Rothstein E, et al. Efficacy of live, attenuated human rotavirus vaccine 89–12 in infants: a randomised placebo-controlled trial. Lancet 1999;354:287-90
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Korhonen T, et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine 2004;22:2836-42
   PubMed Web of Science ®Google Scholar
• European Public Assessment Report, Rotarix INN-human rotavirus, live attenuated. London, UK: European Medicines Agency 2006. Available from: http://www.emea.europa.eu/humandocs/PDFs/EPAR/rotarix/063906en6.pdf [Last accessed 16 June 2009]
   Google Scholar
• Zibrik L, Dove W, Mcardle F, et al. Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers. Arch Virol 2007;152:1951-4
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 2007;370:1757-63
   PubMed Web of Science ®Google Scholar
• Linhares AC, Velázquez FR, Pérez-Schael I, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study. Lancet 2008;371:1144-5
   PubMed Web of Science ®Google Scholar
• Madhi S, Lerumo T, Louw C, et al. Efficacy of human rotavirus vaccine RIX4414 (Rotarix) in South African infants during the first year of life- an interim report. In: Program and abstracts of the 8th International Rotavirus Symposium, Istanbul, 2008
   Google Scholar
• De Vos B, Han HH, Bouckenooghe A, et al. Live attenuated human rotavirus vaccine, RIX4414, provides clinical protection in infants against rotavirus strains with and without shared G and P genotypes: integrated analysis of randomized controlled trials. Pediatr Infect Dis J 2009;28:261-6
   PubMed Web of Science ®Google Scholar
• Ward R. Mechanisms of protection against rotavirus infection and disease. Pediatr Infect Dis J 2009;28(3 Suppl):S57-9. Review
   Web of Science ®Google Scholar
• Ward RL. Rotavirus vaccines: how they work or don't work. Expert Rev Mol Med 2008;10:e5. Published online 12 February 2008, doi:10.1017/S1462399408000574
   PubMedGoogle Scholar
• Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 2003;16(1):17-24
   PubMed Web of Science ®Google Scholar
• Cheuvart B, Friedland LR, Abu-elyazeed R, et al. The human rotavirus vaccine RIX4414 in infants: a review of safety and tolerability. Pediatr Infect Dis J 2009;28:225-32
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006;368:323-32
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global advisory committee on vaccine safety, 17-18 December, 2008. Wkly Epidemiol Rec 2009;84:37-40
   PubMedGoogle Scholar
• Nakagomi T, Cuevas LE, Gurgel RG, et al. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine. Arch Virol 2008;153:591-3
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Nakagomi O. A critical time for rotavirus vaccines: a review. Expert Rev Vaccines 2005;4:521-32
   PubMed Web of Science ®Google Scholar
• Kapikian AZ, Simonsen L, Vesikari T, et al. A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J Infect Dis 2005;192(Suppl 1):S22-9
   PubMed Web of Science ®Google Scholar
• Nakagomi O, Cunliffe NA. Rotavirus vaccines: entering a new stage of deployment. Curr Opin Infect Dis 2007;20:501-7
   PubMed Web of Science ®Google Scholar
• Pun SB, Nakagomi T, Sherchand JB, et al. Detection of G12 human rotaviruses in Nepal. Emerg Infect Dis 2007;1:482-4
   Google Scholar
• Sherchand JB, Nakagomi O, Dove W, et al. Molecular epidemiology of rotavirus diarrhea among children less than 5 years of age in Nepal: predominance of emergent G12 strains over 2 Years. J Infect Dis. (In Press)
   PubMedGoogle Scholar